<DOC>
	<DOCNO>NCT01219465</DOCNO>
	<brief_summary>The purpose study determine whether umbilical cord Mesenchymal Stem Cells treatment initial type 1 diabetes safe effective .</brief_summary>
	<brief_title>Umbilical Cord Mesenchymal Stem Cells Infusion Initial Type 1 Diabetes Mellitus</brief_title>
	<detailed_description>Type 1 diabetes mellitus ( T1DM ) characterize autoimmune destruction pancreatic β cells.Patients require multiple daily insulin injection throughout life well close monitor diet blood sugar level prevent complication . The investigator hope umbilical cord Mesenchymal Stem Cells could address need β-cell replacement also control autoimmune response β cell .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Confirmed diagnosis type 1 diabetes ADA criterion less 9 week . Ability provide write informed consent patient Child guardian . diabetic ketoacidosis . evidence retinopathy baseline . Body Mass Index &gt; 30 . Severe acute organ damage . Infectious disease , e.g . HIV infection , hepatitis B C infection . Severe psychiatric disorder . Presence malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Diabetes Mellitus , Type 1</keyword>
	<keyword>mesenchymal stem cell</keyword>
	<keyword>Umbilical cord</keyword>
</DOC>